Company Filing History:
Years Active: 2015
Title: Yonggang Zhang: Innovator in Radiation Sensitization for Prostate Cancer
Introduction
Yonggang Zhang is a notable inventor based in Nottingham, MD (US). He has made significant contributions to the field of cancer treatment, particularly in the area of radiation sensitization for prostate cancer. His innovative work aims to improve the effectiveness of radiotherapy for neoplastic cells.
Latest Patents
Yonggang Zhang holds a patent for "Radiation sensitization agents for prostate cancer." This invention provides compositions and methods designed to sensitize neoplastic cells to radiotherapy. The patent details the use of aptamer-inhibitory nucleic acid chimeras that selectively inhibit the expression of radiosensitizing genes in neoplastic cells that express a specific cell surface molecule binding the aptamer. He has 1 patent to his name.
Career Highlights
Yonggang Zhang is affiliated with The Johns Hopkins University, where he continues to advance research in cancer therapies. His work is pivotal in developing new strategies to enhance the efficacy of existing treatments for prostate cancer.
Collaborations
Yonggang collaborates with esteemed colleagues such as Shawn Lupold and Theodore L DeWeese. Their combined expertise contributes to the innovative research environment at The Johns Hopkins University.
Conclusion
Yonggang Zhang's contributions to the field of cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work in radiation sensitization represents a significant advancement in the fight against prostate cancer.